1896
DOI: 10.1039/ct8966901287
|View full text |Cite
|
Sign up to set email alerts
|

LXXVI.—The colouring principle contained in the bark of Myrica nagi. Part I

Abstract: Y o r kshire College. resorcinol group, and its distinctive dyeing properties wlicn compared with the above three colouring motters must be due t o this fact.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

1902
1902
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(19 citation statements)
references
References 0 publications
0
19
0
Order By: Relevance
“…Myricetin was first isolated in India from the bark of Myrica nagi Thunb. (Myricaceae) as light yellow-coloured crystals [36]. The compound is recognised mainly for its iron-chelating, anticancer, antioxidant, anti-inflammatory and antidiabetic activities among others [34,37].…”
Section: Discussionmentioning
confidence: 99%
“…Myricetin was first isolated in India from the bark of Myrica nagi Thunb. (Myricaceae) as light yellow-coloured crystals [36]. The compound is recognised mainly for its iron-chelating, anticancer, antioxidant, anti-inflammatory and antidiabetic activities among others [34,37].…”
Section: Discussionmentioning
confidence: 99%
“…It was first isolated in the late eighteenth century from the bark of Myrica nagi Thunb. (Myricaceae), harvested in India, as light yellow-coloured crystals [ 10 ]. Isolation was primarily sparked by interest in the dyeing property of the compound.…”
Section: Introductionmentioning
confidence: 99%
“…Myricetin (3,5,7,3 ,4 ,5 -hexahydroxyflavone cannabiscetin) is a bioflavonoid (Figure 4) widely found in food sources such as vegetables, tea, berries, red wine and medicinal plants. It was first isolated from the bark of the Myrica nagi Thunb, Myricaceae in 1896 with molecular formulae of C 15 H 10 O 8 [86]. Myricetin has been credited for its therapeutic effects in cardiovascular disease [87], cancer [88], and diabetes mellitus [89,90].…”
Section: Myricetinmentioning
confidence: 99%